Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fycompa Titration Intervals and Retention Rate
NCT03457129Phase 4Completed
- Sponsor
- University of Arizona
- Start
- Apr 2018
- Primary completion
- Feb 2021
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of perampanel in epilepsy (2 arms), sponsored by University of Arizona. Primary endpoint: Percentage of Subjects Completing 52 Weeks of Adjunctive Therapy. Started Apr 2018; status: completed.
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT03457129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03457129.